Microbial Colonization of Dairy Free Oral Probiotics

Sponsor
John Hale (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05375396
Collaborator
(none)
30
1
2
2
15

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges containing dairy and dairy free probiotic Streptococcus salivarius M18, in healthy adults

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Streptococcus salivarius M18 lozenges
  • Dietary Supplement: Streptococcus salivarius M18 dairy free lozenges
N/A

Detailed Description

This is a double-blind, randomized controlled colonization pilot study with no cross over to evaluate the colonization efficacy of two different lozenges containing either dairy or dairy free probiotic bacteria Streptococcus salivarius M18.

Participants will be randomly assigned to one of the 2 groups consuming probiotic lozenge containing dairy free Streptococcus salivarius M18 or dairy based Streptococcus salivarius M18 over a seven day period. Saliva samples will be collected at predetermined time points pre and post intervention. Colonization efficacy will be determined by enumerating the probiotic in the saliva samples using standard microbiological techniques.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Probiotic Streptococcus salivarius M18 lozenges Probiotics dairy free Streptococcus salivarius M18 lozengesProbiotic Streptococcus salivarius M18 lozenges Probiotics dairy free Streptococcus salivarius M18 lozenges
Masking:
Double (Participant, Investigator)
Masking Description:
A staff member not part of the study group will be assigned to distribute blinded samples. The participant or the investigators will not be aware of the dose groups.
Primary Purpose:
Basic Science
Official Title:
Assessment of Colonization of Dairy Free Probiotic Bacterium Streptococcus Salivarius From Lozenges to the Oral Cavity
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Streptococcus salivarius M18 lozenges

Streptococcus salivarius M18 lozenges containing dairy based Streptococcus salivarius M18

Dietary Supplement: Streptococcus salivarius M18 lozenges
In this study, a lozenge formulation containing dairy based S. salivarius M18 will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Active Comparator: Streptococcus salivarius M18 dairy free lozenges

Streptococcus salivarius M18 lozenges containing dairy free Streptococcus salivarius M18

Dietary Supplement: Streptococcus salivarius M18 dairy free lozenges
In this study, a lozenge formulation containing dairy free S. salivarius M18 will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Outcome Measures

Primary Outcome Measures

  1. Change in microbial colonization of S. salivarius M18 from Day 0 (baseline) to 1 hour [1 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  2. Change in microbial colonization of S. salivarius M18 from Day 0 (baseline) to 8 hours [8 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  3. Change in microbial colonization of S. salivarius M18 from Day 0 (baseline) to 24 hours [24 hours post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  4. Change in microbial colonization of S. salivarius M18 from Day 0 (baseline) to 48hours [48 hours post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  5. Change in microbial colonization of dairy free S. salivarius M18 from Day 0 (baseline) to 1 hour [1 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  6. Change in microbial colonization of dairy free S. salivarius M18 from Day 0 (baseline) to 8 hour [8 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  7. Change in microbial colonization of dairy free S. salivarius M18 from Day 0 (baseline) to 24 hour [24 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

  8. Change in microbial colonization of dairy free S. salivarius M18 from Day 0 (baseline) to 48 hour [48 hour post intervention]

    Study will determine the change in microbial colonization efficacy of dairy based Streptococcus salivarius M18 in a Lozenge format. The saliva Statistical analysis (e.g. Students t-test) will be carried out to compare the participants data from baseline to one hour after later across two different formulations with the level of significance of p≤0.05.Overall colonization based on percentage of population colonized for different interventions will also be analyzed average and standard deviation functions using appropriate statistical analysis software (e.g. Microsoft Excel).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:

Male or Female 18y - 80y age

  1. In general good health 18 - 80 years of age.

  2. Practice good oral hygiene.

Exclusion criteria:
  1. Have a history of autoimmune disease or are immunocompromised.

  2. Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week

  3. History of allergy (e.g. dairy).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Blis Technologies Ltd Dunedin Otago New Zealand 9012

Sponsors and Collaborators

  • John Hale

Investigators

  • Study Director: John D D Hale, PhD, Blis Technologies Ltd
  • Principal Investigator: Rohit Jain, PhD, Blis Technologies Ltd, Dunedin, New Zealand
  • Study Director: John R Tagg, PhD, Blis Technologies Ltd, Dunedin, New Zealand

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
John Hale, Chief Technology Officer, BLIS Technologies Limited
ClinicalTrials.gov Identifier:
NCT05375396
Other Study ID Numbers:
  • BLTCT2022/4
First Posted:
May 16, 2022
Last Update Posted:
May 16, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by John Hale, Chief Technology Officer, BLIS Technologies Limited
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2022